FDA entrectinib coverage for business development, investment, and market access teams
Roche's NTRK Fusion Therapy receives FDA approval, marking a significant advancement in the treatment of solid tumors with NTRK gene fusions.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
